WNT4 is known to be overexpressed in uterine leiomyomas with MED12 mutations (Markowski et al., 2012), and knock-down of MED12 in UL cells reduces WNT4 expression (Al-Hendy et al., 2017). This evidence concerns the gene WNT4 and uterine corpus leiomyoma.